Use of digital measurement of medication adherence and lung function to guide the management of uncontrolled asthma (INCA Sun): a multicentre, single-blinded, randomised clinical trial - The Lancet Respiratory Medicine
Lancet, NEJM retract Covid-19 studies that sparked backlash
Use of secondary prevention drugs for cardiovascular disease in the community in high-income, middle-income, and low-income countries (the PURE Study): a prospective epidemiological survey - The Lancet
Pathophysiology, prevention, and treatment of medication overuse headache - The Lancet Neurology
Antihypertensive medications and risk for incident dementia and Alzheimer's disease: a meta-analysis of individual participant data from prospective cohort studies - The Lancet Neurology
Drug Evidence Watch for Public Health Benefit
Immunogenicity, safety, and tolerability of a recombinant measles-vectored Lassa fever vaccine: a randomised, placebo-controlled, first-in-human trial - The Lancet
The Lancet, 06 January 2024, Volume 403, Issue 10421, Pages 1-116, e1
More people could benefit from antihypertensives, study finds
Implementation of a mobile health clinic framework for Hepatitis C virus screening and treatment: a descriptive study - The Lancet Regional Health – Americas
Some patients not receiving ADHD treatment, despite overall increase | UCL News - UCL – University College London
Maintenance therapy after quadruple induction therapy in HIV-1 infected individuals: Amsterdam Duration of Antiretroviral Medication (ADAM) study - The Lancet
Initiation of pharmacological therapy in Parkinson's disease: when, why, and how - The Lancet Neurology
Drug harms in the UK: a multicriteria decision analysis - The Lancet
Antipsychotic drug effective and safe in paranoid older people who usually aren't treated | UCL News - UCL – University College London
Cognitive outcomes at age 3 years in children with fetal exposure to antiseizure medications (MONEAD study) in the USA: a prospective, observational cohort study - The Lancet Neurology
Is this pill an antibiotic or a painkiller? Improving the identification of oral antibiotics for better use - The Lancet Global Health
Use of digital measurement of medication adherence and lung function to guide the management of uncontrolled asthma (INCA Sun): a multicentre, single-blinded, randomised clinical trial - The Lancet Respiratory Medicine
eClinicalMedicine Home Page
Effect of dronabinol on progression in progressive multiple sclerosis (CUPID): a randomised, placebo-controlled trial - The Lancet Neurology
Methotrexate plus ustekinumab versus ustekinumab monotherapy in patients with active psoriatic arthritis (MUST): a randomised, multicentre, placebo-controlled, phase 3b, non-inferiority trial - The Lancet Rheumatology
Caution: coloured medication and the colour blind - The Lancet
The Lancet Psychiatry, January 2024, Volume 11, Issue 1, Pages 1-80, e1-e3
